+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region

  • PDF Icon

    Report

  • 200 Pages
  • March 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5941894
The global biobetters market size was estimated to be USD 46.78 billion in 2023 and is expected to reach USD 112.12 billion by 2034 with a CAGR of 8.27% during the forecast period 2024-2034. The demand for enhanced efficacy and safety, advancements in biotechnology and protein engineering, the growing biopharmaceutical market, patient demand for personalized medicine, and collaborations and partnerships will drive the market growth.

A favorable environment for the development of biobetters is created by the market's general expansion for biopharmaceuticals, which includes monoclonal antibodies and other biologics. The market for biobetters is growing as a result of the growing acceptance and application of biologics in a range of therapeutic fields. For instance, in October 2023, Alector Biosciences and Roche announced a partnership to co-develop biobetters for neurodegenerative illnesses.

By drug class, the monoclonal antibodies biobetters segment accounted for the highest revenue-grossing segment in the global biobetters market in 2023 owing to the innovative modifications and advancements made in monoclonal antibody engineering, resulting in enhanced therapeutic efficacy, improved safety profiles, and increased patient acceptance. For instance, Novartis will introduce Kanjinti (a biosimilar of trastuzumab) in July 2023 to treat HER2-positive breast cancer and HER2-positive metastatic gastric cancer. Additionally, the insulin biobetters segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising prevalence of diabetes worldwide and the imperative need for more effective and patient-friendly insulin therapies.

By disease indication, the cancer segment accounted for the highest revenue-grossing segment in the global biobetters market in 2023 owing to the increased prevalence of various cancer types, driving the demand for more effective and targeted therapeutic interventions. For instance, Pfizer announced favorable Phase 3 results in October 2023 for ABP 738, a biosimilar of pegfilgrastim used to reduce neutropenia. Additionally, the neurodegenerative diseases segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing global prevalence of neurodegenerative diseases, such as Alzheimer's and Parkinson's, and the pressing need for advanced therapeutic options.

By route of administration, the subcutaneous segment accounted for the highest revenue-grossing segment in the global biobetters market in 2023 owing to the increasing preference for patient-friendly and convenient administration routes, coupled with the advantages of subcutaneous delivery in terms of improved bioavailability and reduced side effects. For instance, Johnson & Johnson completes the purchase of Abiomed in December 2023, broadening its range of cardiovascular devices and maybe opening the door for biobetter integration for the treatment of heart failure. Additionally, the intravenous segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing demand for rapid onset of action, precise dosage control, and the ability to administer larger volumes of biobetters in critical therapeutic situations.

By distribution channel, the hospital pharmacies segment accounted for the highest revenue-grossing segment in the global biobetters market in 2023 owing to the prevalent practice of administering biobetters in a hospital setting, where complex and specialized therapies can be managed by healthcare professionals. For instance, Eli Lilly and Company said in June 2023 that it will be working with Elly Lilly Japan to develop and market biobetters for autoimmune illnesses. Additionally, the retail pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising trend of patient-centric care and the expanding role of retail pharmacies in providing convenient access to biobetters for chronic conditions and long-term treatments.

North American region is anticipated to have the highest revenue share during the forecast period owing to the robust presence of key biopharmaceutical companies, a well-established healthcare infrastructure, and a high prevalence of chronic diseases driving the demand for advanced therapeutic solutions. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of chronic diseases, a rapidly expanding healthcare infrastructure, and a growing emphasis on biotechnology and pharmaceutical research and development. For instance, AbbVie and Regeneron will collaborate to develop a biobetter in October 2023 to treat age-related macular degeneration (AMD).

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Drug Class, Disease Indication, Route of Administration, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement.

Segmentation: Biobetters Market Report 2023 - 2034

Biobetters Market Analysis & Forecast by Drug Class 2023 - 2034 (Revenue USD Bn)

  • Erythropoietin biobetters
  • Insulin biobetters
  • G-CSF biobetters
  • Interferon biobetters
  • Monoclonal antibodies biobetters
  • Anti-hemophilic factors
  • Other biobetters

Biobetters Market Analysis & Forecast by Disease Indication 2023 - 2034 (Revenue USD Bn)

  • Diabetes
  • Cancer
  • Renal disease
  • Neurodegenerative diseases
  • Genetic disorders
  • Others

Biobetters Market Analysis & Forecast by Route of Administration 2023 - 2034 (Revenue USD Bn)

  • Subcutaneous
  • Intravenous
  • Others

Biobetters Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Biobetters Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Biobetters Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Biobetters Market: Drug Class Estimates & Trend Analysis
7.1. Drug Class Segment Opportunity Analysis
7.2. Erythropoietin biobetters
7.2.1. Erythropoietin biobetters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Insulin biobetters
7.3.1. Insulin biobetters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. G-CSF biobetters
7.4.1. G-CSF biobetters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Interferon biobetters
7.5.1. Interferon biobetters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Monoclonal antibodies biobetters
7.6.1. Monoclonal antibodies biobetters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.7. Anti-hemophilic factors
7.7.1. Anti-hemophilic factors Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.8. Other biobetters
7.8.1. Other biobetters Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Biobetters Market: Disease Indication Estimates & Trend Analysis
8.1. Disease Indication Segment Opportunity Analysis
8.2. Diabetes
8.2.1. Diabetes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Cancer
8.3.1. Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Renal disease
8.4.1. Renal Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Neurodegenerative diseases
8.5.1. Neurodegenerative Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.6. Genetic disorders
8.6.1. Genetic disorders Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.7. Others
8.7.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Biobetters Market: Route of Administration Estimates & Trend Analysis
9.1. Route of Administration Segment Opportunity Analysis
9.2. Subcutaneous
9.2.1. Subcutaneous Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Intravenous
9.3.1. Intravenous Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Others
9.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Biobetters Market: Distribution Channel Estimates & Trend Analysis
10.1. Distribution Channel Segment Opportunity Analysis
10.2. Hospital Pharmacies
10.2.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.3. Retail Pharmacies
10.3.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10.4. Online Pharmacies
10.4.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
11. Regional Market Analysis
11.1. Regional Market Opportunity Analysis
12. North America Biobetters Market
12.1. North America Biobetters Market
12.1.1. North America Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. North America Biobetters Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. North America Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.1.4. North America Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
12.1.5. North America Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.1.6. North America Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. U.S. Global Biobetters Market
12.2.1. U.S. Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. U.S. Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.2.3. U.S. Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
12.2.4. U.S. Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.2.5. U.S. Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. Canada Global Biobetters Market
12.3.1. Canada Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. Canada Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.3.3. Canada Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
12.3.4. Canada Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.3.5. Canada Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Europe Global Biobetters Market
13.1. Europe Global Biobetters Market
13.1.1. Europe Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Europe Biobetters Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Europe Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.1.4. Europe Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.1.5. Europe Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.1.6. Europe Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Germany Global Biobetters Market
13.2.1. Germany Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Germany Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.2.3. Germany Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.2.4. Germany Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.2.5. Germany Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. UK Global Biobetters Market
13.3.1. UK Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. UK Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.3.3. UK Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.3.4. UK Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.3.5. UK Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. France Global Biobetters Market
13.4.1. France Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. France Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.4.3. France Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.4.4. France Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.4.5. France Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. Spain Global Biobetters Market
13.5.1. Spain Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Spain Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.5.3. Spain Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.5.4. Spain Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.5.5. Spain Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Italy Global Biobetters Market
13.6.1. Italy Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Italy Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.6.3. Italy Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.6.4. Italy Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.6.5. Italy Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Europe Global Biobetters Market
13.7.1. Rest of Europe Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Europe Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Europe Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Europe Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.7.5. Rest of Europe Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Asia Pacific Global Biobetters Market
14.1. Asia Pacific Global Biobetters Market
14.1.1. Asia Pacific Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Asia Pacific Biobetters Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Asia Pacific Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.1.4. Asia Pacific Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.1.5. Asia Pacific Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.1.6. Asia Pacific Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Japan Global Biobetters Market
14.2.1. Japan Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Japan Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.2.3. Japan Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.2.4. Japan Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.2.5. Japan Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. China Global Biobetters Market
14.3.1. China Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. China Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.3.3. China Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.3.4. China Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.3.5. China Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. India Global Biobetters Market
14.4.1. India Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. India Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.4.3. India Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.4.4. India Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.4.5. India Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. South Korea Global Biobetters Market
14.5.1. South Korea Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. South Korea Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.5.3. South Korea Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.5.4. South Korea Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.5.5. South Korea Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.6. Australia Global Biobetters Market
14.6.1. Australia Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.6.2. Australia Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.6.3. Australia Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.6.4. Australia Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.6.5. Australia Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.7. Rest of Asia Pacific Global Biobetters Market
14.7.1. Rest of Asia Pacific Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.7.2. Rest of Asia Pacific Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.7.3. Rest of Asia Pacific Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
14.7.4. Rest of Asia Pacific Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.7.5. Rest of Asia Pacific Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. Latin America Global Biobetters Market
15.1. Latin America Global Biobetters Market
15.1.1. Latin America Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. Latin America Biobetters Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. Latin America Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.1.4. Latin America Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.1.5. Latin America Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.1.6. Latin America Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. Brazil Global Biobetters Market
15.2.1. Brazil Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. Brazil Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.2.3. Brazil Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.2.4. Brazil Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.2.5. Brazil Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. Mexico Global Biobetters Market
15.3.1. Mexico Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. Mexico Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.3.3. Mexico Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.3.4. Mexico Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.3.5. Mexico Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Argentina Global Biobetters Market
15.4.1. Argentina Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Argentina Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.4.3. Argentina Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.4.4. Argentina Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.4.5. Argentina Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.5. Rest of Latin America Global Biobetters Market
15.5.1. Rest of Latin America Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.5.2. Rest of Latin America Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.5.3. Rest of Latin America Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
15.5.4. Rest of Latin America Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.5.5. Rest of Latin America Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. MEA Global Biobetters Market
16.1. MEA Global Biobetters Market
16.1.1. MEA Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.1.2. MEA Biobetters Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
16.1.3. MEA Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.1.4. MEA Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.1.5. MEA Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.1.6. MEA Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.2. GCC Global Biobetters Market
16.2.1. GCC Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.2.2. GCC Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.2.3. GCC Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.2.4. GCC Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.2.5. GCC Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.3. South Africa Global Biobetters Market
16.3.1. South Africa Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.3.2. South Africa Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.3.3. South Africa Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.3.4. South Africa Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.3.5. South Africa Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16.4. Rest of MEA Global Biobetters Market
16.4.1. Rest of MEA Biobetters Market Size and Forecast, 2023-2034 (Revenue USD Bn)
16.4.2. Rest of MEA Biobetters Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
16.4.3. Rest of MEA Biobetters Market Size and Forecast, By Disease Indication, 2023-2034 (Revenue USD Bn)
16.4.4. Rest of MEA Biobetters Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
16.4.5. Rest of MEA Biobetters Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
17. Competitor Analysis
17.1. Company Market Share Analysis, 2023
17.2. Major Recent Developments
18. Company Profiles
18.1. Roche
18.2. Amgen
18.3. Novartis
18.4. Pfizer
18.5. Johnson & Johnson
18.6. Eli Lilly and Company
18.7. AbbVie
18.8. Biogen
18.9. AstraZeneca
18.10. Sanofi
18.11. Merck & Co.
18.12. Genentech (a member of the Roche Group)
18.13. Celgene (acquired by Bristol Myers Squibb)
18.14. Teva Pharmaceuticals
18.15. Samsung Bioepis
19. Conclusion20. Recommendations

Companies Mentioned

  • Roche
  • Amgen
  • Novartis
  • Pfizer
  • Johnson & Johnson
  • Eli Lilly and Company
  • AbbVie
  • Biogen
  • AstraZeneca
  • Sanofi
  • Merck & Co.
  • Genentech (a member of the Roche Group)
  • Celgene (acquired by Bristol Myers Squibb)
  • Teva Pharmaceuticals
  • Samsung Bioepis.

Table Information